IDEXX LABORATORIES INC /DE Cash & Equivalents 2007-2026 | IDXX
What is cash & equivalents?
Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.
What is IDEXX LABORATORIES INC /DE's current cash & equivalents?
IDEXX LABORATORIES INC /DE (IDXX) annual cash & equivalents for 2025 was $180.1M, a 37.53% decline from 2024. IDEXX LABORATORIES INC /DE cash & equivalents for the quarter ending March 31, 2026 was $200.5M.
What was IDEXX LABORATORIES INC /DE's cash & equivalents in 2024?
IDEXX LABORATORIES INC /DE annual cash & equivalents for 2024 was $288.3M, a 36.50% decline from 2023.
What was IDEXX LABORATORIES INC /DE's cash & equivalents in 2023?
IDEXX LABORATORIES INC /DE annual cash & equivalents for 2023 was $453.9M, a 303.33% increase from 2022.
What is IDEXX LABORATORIES INC /DE's 5-year cash & equivalents CAGR?
IDEXX LABORATORIES INC /DE cash & equivalents grew at a compound annual growth rate (CAGR) of 14.05% from FY2020 to FY2025, going from $383.9M to $180.1M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $180.1M | -37.5% | 10-K |
| FY2024 | $288.3M | -36.5% | 10-K |
| FY2023 | $453.9M | +303.3% | 10-K |
| FY2022 | $112.5M | -22.1% | 10-K |
| FY2021 | $144.5M | -62.4% | 10-K |
| FY2020 | $383.9M | +325.0% | 10-K |
| FY2019 | $90.3M | -27.0% | 10-K |
| FY2018 | $123.8M | -34.0% | 10-K |
| FY2017 | $187.7M | +21.2% | 10-K |
| FY2016 | $154.9M | +20.1% | 10-K |
| FY2015 | $129.0M | -60.0% | 10-K |
| FY2014 | $322.5M | +15.6% | 10-K |
| FY2013 | $279.1M | +24.6% | 10-K |
| FY2012 | $224.0M | +21.8% | 10-K |
| FY2011 | $183.9M | +17.2% | 10-K |
| FY2010 | $156.9M | +47.0% | 10-K |
| FY2009 | $106.7M | +35.3% | 10-K |
| FY2008 | $78.9M | +30.7% | 10-K |
| FY2007 | $60.4M | - | 10-K |